Stratistics MRC에 따르면 세계의 뇌파 검사 기기 시장은 2025년에 15억 달러를 차지하고 예측 기간 동안 CAGR 11.8%를 나타내 2032년에는 32억 달러에 이를 전망입니다.
뇌파계는 뇌의 전기적 활동을 측정·기록하기 위한 의료기기입니다.두피에 장착한 전극을 통해 뇌파 패턴을 검출해, 간질, 수면장애, 뇌 손상 등의 신경학적 상태의 진단에 도움이 됩니다.
미국 질병통제예방센터(CDC)에 따르면 2022년 미국에서는 510만 명 이상이 뇌전증 병력을 가지고 있었으며, 현재 340만 명이 뇌전증을 앓고 있습니다.
신경 질환의 유병률 증가
간질, 알츠하이머병, 파킨슨병 등 신경질환의 이환율 증가는 뇌파 검사 기기 수요를 크게 견인하고 있습니다. 기여하고 있습니다.또한, 뇌파 검사 기기(EEG) 기술의 진보가 비침습적 진단의 매력을 높여, 뇌 활동의 모니터링에 선호되는 선택지가 되고 있습니다.
개발 도상 지역에서의 제한된 접근
신흥국 시장에서는 첨단 EEG 기술에 대한 접근이 제한되어 시장 성장을 방해하고 있습니다. 환불 정책이 제한되어 있다는 점도 채용을 더욱 제한하고 있습니다.
AI와 머신러닝의 통합
뇌파 분석에서 AI와 머신러닝의 통합은 시장 성장에 큰 기회가 되고 있습니다., 데이터 분석을 자동화하고 전문 지식의 필요성을 줄일 수 있습니다.
대체 신경 영상 기술과의 경쟁
뇌파 검사 기기는 MRI, CT, PET 스캔과 같은 고급 신경 영상 도구와의 경쟁에 직면하고 있으며, 이러한 도구는 뇌의 구조적 평가를 위해 높은 공간 분해능을 제공합니다. 그러면 멀티모달 진단이 선호되기 때문에 단독 사용에는 과제가 있습니다. 또한 대체기술에 대한 연구개발투자가 증가함에 따라 초점이 맞을 수 있으며 뇌파 검사 기기 시스템의 관련성을 유지하기 위해서는 지속적인 기술 혁신이 필요합니다.
COVID-19의 대유행은 뇌파 검사 기기를 포함한 원격 모니터링 기술의 중요성을 돋보이게 했습니다. 원격 의료 및 재택 모니터링 솔루션에 대한 주목이 높아져 뇌파 검사 기기 시장에 혜택을 가져왔습니다.
예측기간 중 병원 및 진료소 부문이 최대가 될 전망
병원 및 진료소 부문은 환자수가 많음, 고급 인프라, 숙련된 인재에 의해 예측 기간 중 최대 시장 점유율을 차지할 것으로 예상되고 있습니다. G를 활용하고 있으며, 임상시험을 위한 학술기관과의 제휴가 이 분야의 리더십을 강화하고 있습니다.
예측 기간 동안 웨어러블 디바이스 분야의 CAGR이 가장 높을 것으로 예상
예측 기간 동안 웨어러블 디바이스 분야는 재택 모니터링과 만성 질환 관리 수요에 힘입어 가장 높은 성장률을 보일 것으로 예측되고 있습니다. 마트폰과 IoT 플랫폼과의 통합은 실시간 분석을 지원하여 소비자와 임상의에게 어필합니다.
예측 기간 동안 북미는 첨단 의료 제도, 높은 R&D 투자, Natus Medical 및 Cadwell Industries와 같은 주요 기업의 강력한 존재로 인해 가장 큰 시장 점유율을 차지할 것으로 예상됩니다.
예측 기간 동안 아시아태평양이 가장 높은 CAGR을 나타낼 것으로 예측되며, 그 원동력은 헬스케어 접근의 개선, 신경질환에 대한 의식 증가짐, 의료 투어리즘의 확대입니다. 화에 투자해, 일본은 고령화가 수요를 밀어 올리고 있습니다. 또한, 비용 대비 효과가 있는 EEG 시스템을 제공하는 현지 제조업체나 세계 기업과의 제휴가 시장 침투를 가속시켜, 이 지역을 고성장 허브로서 자리매김하고 있습니다.
According to Stratistics MRC, the Global Electroencephalography Devices Market is accounted for $1.5 billion in 2025 and is expected to reach $3.2 billion by 2032 growing at a CAGR of 11.8% during the forecast period. Electroencephalography (EEG) devices are medical instruments used to measure and record electrical activity in the brain. They detect brain wave patterns through electrodes placed on the scalp, aiding in diagnosing neurological conditions like epilepsy, sleep disorders, and brain injuries. EEG devices range from portable to clinical-grade systems and are essential in research, neurology, and cognitive studies for monitoring brain function and assessing abnormalities in neural activity.
According to the Centers for Disease Control and Prevention (CDC), in 2022, over 5.1 million people in the U.S. had a history of epilepsy, with 3.4 million currently affected.
Increasing prevalence of neurological disorders
The rising incidence of neurological conditions such as epilepsy, Alzheimer's, and Parkinson's disease significantly drives the demand for EEG devices. Furthermore, the growing geriatric population and increased awareness about early diagnosis contribute to market growth. Additionally, advancements in EEG technology enhance its appeal for non-invasive diagnostics, making it a preferred choice for monitoring brain activity. This trend is expected to continue, bolstering the market's expansion.
Limited access in developing regions
Limited access to advanced EEG technology in developing regions hinders market growth. High costs and inadequate healthcare infrastructure discourage investments in these areas. Moreover, restricted reimbursement policies for EEG services further limit adoption. Smaller hospitals and clinics often lack the resources to purchase and maintain sophisticated EEG systems, creating barriers to widespread adoption.
Integration of Ai and machine learning
The integration of AI and machine learning in EEG analysis presents significant opportunities for market growth. These technologies enhance diagnostic accuracy and enable predictive insights, fostering innovation in personalized medicine. Furthermore, AI-driven EEG systems can automate data interpretation, reducing the need for specialized expertise. Additionally, strategic collaborations and research funding are crucial for capitalizing on these opportunities, driving the development of more sophisticated EEG devices.
Competition from alternative neuroimaging techniques
EEG devices face competition from advanced neuroimaging tools like MRI, CT, and PET scans, which offer higher spatial resolution for structural brain assessments. While EEG excels in temporal resolution and cost-effectiveness, preference for multi-modal diagnostics in complex cases challenges its standalone use. Additionally, rising R&D investments in alternative technologies may divert focus, necessitating continuous innovation in EEG systems to maintain relevance.
The COVID-19 pandemic highlighted the importance of remote monitoring technologies, including EEG devices. However, supply chain disruptions and budget constraints initially slowed market growth. As economies recover, the focus on telehealth and home-based monitoring solutions has increased, benefiting the EEG market. Furthermore, the pandemic accelerated the adoption of digital health technologies, positioning EEG devices for long-term growth.
The hospitals and clinics segment is expected to be the largest during the forecast period
The hospitals and clinics segment is expected to account for the largest market share during the forecast period, due to high patient footfall, advanced infrastructure, and skilled personnel. These settings utilize EEG for critical diagnoses, surgical monitoring, and research, supported by favorable reimbursement policies. Additionally, partnerships with academic institutions for clinical trials reinforce segment leadership. The U.S. led in hospital-based EEG adoption, driven by robust healthcare frameworks and rising neurological disorder prevalence.
The wearable devices segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the wearable devices segment is predicted to witness the highest growth rate, fueled by demand for home-based monitoring and chronic disease management. Lightweight, wireless designs enhance patient comfort, enabling long-term data collection. Moreover, integration with smartphones and IoT platforms supports real-time analytics, appealing to both consumers and clinicians. Startups focusing on epilepsy and sleep disorder wearables drive innovation, positioning this segment for rapid expansion.
During the forecast period, the North America region is expected to hold the largest market share, due to advanced healthcare systems, high R&D investments, and strong presence of key players like Natus Medical and Cadwell Industries. High neurological disorder prevalence and insurance coverage further propel demand. Additionally, FDA approvals for AI-enhanced EEG devices and government funding for brain research sustain market dominance.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, driven by improving healthcare access, rising neurological disease awareness, and expanding medical tourism. Countries like India and China invest in modernizing diagnostics, while Japan's aging population boosts demand. Furthermore, local manufacturers offering cost-effective EEG systems and partnerships with global firms accelerate market penetration, positioning the region as a high-growth hub.
Key players in the market
Some of the key players in Electroencephalography Devices Market include Natus Medical Incorporated, Medtronic plc, Nihon Kohden Corporation, Cadwell Industries, Inc., NeuroWave Systems Inc., Electrical Geodesics, Inc. (EGI), Compumedics Limited, Koninklijke Philips N.V., GE Healthcare, Advanced Brain Monitoring, Inc., Brain Products GmbH, BioSemi, Emotiv, NeuroSky, g.tec medical engineering GmbH, ANT Neuro, Cephalon A/S and Noraxon U.S.A., Inc.
In January 2025, Brain Products released BrainVision Recorder 1.27.0001 and BrainVision Recorder for CGX 2.01.0102.
In January 2025, Emotiv, a global leader in EEG technology, announces its next-generation EEG Active Noise-Cancelling Earphones. These smart earphones enhance personal wellness by integrating advanced EEG technology to provide insights into cognitive performance and overall well-being-alongside exceptional sound quality.
In January 2024, Compumedics Limited is pleased to announce new MEG orders from Tsinghua and Tianjin Universities in China. These sales are via Compumedics' long-term Chinese distributor and partner, Beijing Fistar. The MEG systems, along with a host of peripherals including simultaneous EEG, stimulators, computers, and CURRY neuroimaging software, will ship to both sites in 2025. One order is for two single-helmet MEG systems, and the other is for a dual-helmet MEG system. Both will be configured for hyperscanning.